Angewandte
Chemie
Enzyme Reaction Mechanisms
DOI: 10.1002/anie.200501670
A Method for Trapping Intermediates of Poly-
ketide Biosynthesis with a Nonhydrolyzable
Malonyl-Coenzyme A Analogue**
Dieter Spiteller, Claire L. Waterman, and
Jonathan B. Spencer*
There are currently about 10000 natural products that have
been classified as polyketides. Their structures range from
simple molecules, such as 6-methylsalicylic acid,[1] to complex
natural products, such as brevetoxin.[2] Polyketides are an
invaluable source of bioactive compounds with many being
clinically important, for example, the antibiotic erythromycin
and the immunosupressant rapamycin.[3] Despite their diver-
sity, all polyketides share a common biosynthetic pathway; a
starter unit, which is normally acetyl coenzyme A (CoA),
undergoes sequential condensation with an extender unit
(usually malonyl or (S)-methylmalonyl-CoA) in a similar
manner to fatty acid biosynthesis. However, unlike fatty acid
biosynthesis, the carbonyl group is not always completely
reduced after each condensation, which partly accounts for
the huge variety of polyketide structures (Scheme 1).[3]
Scheme 1. Schematic diagram of the mechanism of two rounds of
polyketide biosynthesis by a polyketide synthase (AT: acyl transferase,
KS: ketosynthase, ACP: acyl carrier protein, DH: dehydratase, KR:
ketoreductase). In type III polyketide synthases, such as the stilbene
synthase from Pinus sylvestris, malonyl-CoA is used directly for the
elongation instead of the corresponding ACPs.
Experiments with labeled precursors, in combination with
mechanistic considerations, have been extensively used to
investigate the details of polyketide biosynthesis.[1,3] How-
ever, it has proven very difficult to isolate intermediates
directly as they are covalently attached to the polyketide
synthases (PKSs).[3] One approach that has been possible with
the cloning and sequencing of genes for many PKSs[4] is to
design mutants that halt the biosynthesis at a desired point.
For instance, by genetically engineering the fusion of the
thioesterase from the third subunit of the deoxyerythronolide
synthase onto the first subunit, deoxyerythronolide biosyn-
thesis was stopped after two rounds of (S)-methylmalonyl-
CoA condensations and the intermediate removed in suffi-
cient quantity to be fully characterized.[5] Whereas this
strategy has potential with all type I modular PKSs, it is
very limited when applied to type I iterative, type II, and
type III PKSs, as the same catalytic activities are usually used
repeatedly. For example, if a mutation is made in the
ketosynthase, polyketide synthesis could not occur at all. To
address this point, we sought to develop a chemical approach
that used a non-hydrolyzable malonyl-CoA analogue which
can potentially trap polyketide intermediates from these
classes of PKSs.
Analogues of coenzyme A[6–8] have been used previously
to investigate a range of enzyme reaction mechanisms, such as
the condensation of acetyl-CoA with oxaloacetate catalyzed
by citrate synthase[7] and the enzymic carboxylation of acetyl-
CoA by acetyl-CoA carboxylase.[9] However, malonyl-CoA
analogues have never been used before to investigate the
biosynthesis of polyketides. In our strategy, the malonyl-CoA
analogue would react with the growing polyketide chain but
would not be able to undergo transesterification back onto
the PKS resulting in the accumulation of polyketide inter-
mediates attached to the analogue (Scheme 2a).
[*] C. L. Waterman, Dr. J. B. Spencer
UniversityChemical Laboratory
Universityof Cambridge
Lensfield Road, Cambridge, CB21EW (UK)
Fax: (+44)1223-336-362
E-mail: jbs20@cam.ac.uk
Dr. D. Spiteller
Department of Biochemistry
Universityof Cambridge
80 Tennis Court Road, Cambridge CB21GA (UK)
The analogue of malonyl-CoA 3 used in this study
contains an additional methylene unit between the thiol of
the coenzyme A and the malonate moiety. This methylene
unit could possibly be detrimental to the correct positioning
of the analogue at the active site of a PKS, as the malonyl
moiety is displaced by one carbon atom. However, we felt that
this potential disadvantage was out-weighed by the straight-
forward preparation of 3 in two steps. Commercially available
ethyl 4-chloro-3-oxobutanoate (1) was treated with coenzy-
me A in aqueous 0.11m Li2CO3.[7,8] After purification with
[**] We are indebted to Prof. Dr. Joachim Schröder (Institut für Biologie
II, Biochemie der Pflanzen, Freiburg (Germany)) for providing the
cDNA of stilbene synthase and to Prof. Dr. Fraser (University of
Calgary, Canada) for the gift of a plasmid coding for the succinyl-
CoA:3-ketoacid transferase. D.S. thanks the Deutschen Akademie
der Naturforscher Leopoldina (Germany), for a postdoctoral
fellowship (BMBF-LPD 9901/8-90). Financial support bythe BBSRC
is gratefullyacknowledged.
Supporting information for this article is available on the WWW
Angew. Chem. Int. Ed. 2005, 44, 7079 –7082
ꢀ 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
7079